Jump to section
To increase diagnostic accuracy and improve patient care and the efficiency of clinical practices for health professionals.
Gleamer, a French medtech startup founded in 2017, has developed a suite of AI-powered solutions to help radiologists detect and diagnose bone trauma lesions in scans, among other conditions.
Its flagship product, BoneView, assists radiologists in identifying bone trauma lesions and other subtle abnormalities that may go unnoticed by the human eye. Additionally, Gleamer has developed ChestView for detecting pulmonary pathologies, BoneMeasurement for automating MSK measurements, and BoneAge for estimating bone age with precision.
Recognising the growing demand for medical imaging services, Gleamer has successfully raised new capital to further its advancements. With this funding, the company aims to expand its product portfolio to encompass CT scans and mammography, providing even more diagnostic capabilities. Additionally, Gleamer plans to bolster its teams in both Europe and the US, enabling broader access to its technologies and facilitating collaboration with medical professionals worldwide.
Kirsty
Company Specialist at Welcome to the Jungle
Dec 2024
$4.8m
GRANT
Jun 2023
$28.4m
SERIES B
This company has top investors
Christian Allouche
(CEO & Co-Founder)Graduated from ESCP Business School with a Master's degree in Management, Economics and Finance. Previously co-founded BrainVectis and served as the CEO at MeltingDoc.
Nor-eddine Regnard
(Chief Medical Officer & Co-Founder)Previously worked as a Teacher at Paris Descartes University, Montpellier University and Pierre and Marie Curie University. They are now a Partner Radiologist at RISF South France Imaging Network.
Alexis Ducarouge
(CTO & Co-Founder)Graduated from the École Normale Supérieure with a Master's degree in Cognitive Science and Artificial Intelligence.